Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1521205
PUBLISHER: IMARC | PRODUCT CODE: 1521205
Oncology Based In-Vivo CRO Market Report by Indication (Blood Cancer, Solid Tumors, and Others), Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX), and Others), Application (Hospitals, Rehabilitation Centers), and Region 2024-2032
PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global oncology based in-vivo CRO market size reached US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2024-2032.
Oncology refers to a branch of medicine that studies, diagnoses, and treats cancer using biopsy, endoscopy, X-ray, computed tomography (CT) scanning, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and ultrasound. It offers hormonal therapy, immunotherapy, radiotherapy, and oral therapies to patients for tolerating and easing the side effects of cancer. At present, there is a rise in the demand for oncology based in-vivo CRO across the globe due to the development of several investigational compounds by contract research organizations (CROs) for treating cancer.
Oncology Based In-Vivo CRO Market Trends:
The growing prevalence of cancer around the world represents one of the key factors driving the market. Moreover, governments of several countries across the globe are extensively investing in research and development (R&D) activities. This, along with the rising expertise in cancer treatment by contract research organizations (CROs), is propelling the growth of the market. In addition, there is an increase in the innovation of genetic engineering for manipulating deoxyribonucleic acid (DNA) and altering the characteristics of organisms. This, coupled with the growing focus on oncogene study to regulate proliferation, growth, and differentiation of cells, is positively influencing the market. Besides this, the wide availability of medicines, along with the expanding healthcare industry, is catalyzing the demand for oncology based in-vivo CRO worldwide. Apart from this, the cost-efficiency offered by contract research organizations (CROs) compared to an in-house study is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the adoption of telehealth and virtual clinical trials in the healthcare industry for ensuring the safety of cancer patients. This is projected to bolster the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology based in-vivo CRO market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on indication, model and application.
Breakup by Indication:
Blood Cancer
Solid Tumors
Others
Breakup by Model:
Syngeneic
Xenograft
Patient Derived Xenograft (PDX)
Others
Breakup by Application:
Hospitals
Rehabilitation Centers
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Champions Oncology Inc., Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific, Evotec SE, ICON Plc, Labcorp Drug Development (Laboratory Corporation of America Holdings), Living Tumor Laboratory, Taconic Biosciences Inc., The Jackson Laboratory, WuXi AppTec and Xentech.
Key Questions Answered in This Report
- 1. What was the size of the global oncology based in-vivo CRO market in 2023?
- 2. What is the expected growth rate of the global oncology based in-vivo CRO market during 2024-2032?
- 3. What are the key factors driving the global oncology based in-vivo CRO market?
- 4. What has been the impact of COVID-19 on the global oncology based in-vivo CRO market?
- 5. What is the breakup of the global oncology based in-vivo CRO market based on the indication?
- 6. What is the breakup of the global oncology based in-vivo CRO market based on the model?
- 7. What are the key regions in the global oncology based in-vivo CRO market?
- 8. Who are the key players/companies in the global oncology based in-vivo CRO market?
Product Code: SR112024A5438
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Oncology Based In-Vivo CRO Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Indication
- 6.1 Blood Cancer
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Solid Tumors
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Model
- 7.1 Syngeneic
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Xenograft
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Patient Derived Xenograft (PDX)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Application
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Rehabilitation Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Champions Oncology Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.2 Charles River Laboratories International Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Crown Bioscience Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Eurofins Scientific
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Evotec SE
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 ICON Plc
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Labcorp Drug Development (Laboratory Corporation of America Holdings)
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 SWOT Analysis
- 14.3.8 Living Tumor Laboratory
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Taconic Biosciences Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 The Jackson Laboratory
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 WuXi AppTec
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.12 Xentech
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.1 Champions Oncology Inc.
Product Code: SR112024A5438
List of Figures
- Figure 1: Global: Oncology Based In-Vivo CRO Market: Major Drivers and Challenges
- Figure 2: Global: Oncology Based In-Vivo CRO Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Oncology Based In-Vivo CRO Market: Breakup by Indication (in %), 2023
- Figure 5: Global: Oncology Based In-Vivo CRO Market: Breakup by Model (in %), 2023
- Figure 6: Global: Oncology Based In-Vivo CRO Market: Breakup by Application (in %), 2023
- Figure 7: Global: Oncology Based In-Vivo CRO Market: Breakup by Region (in %), 2023
- Figure 8: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Oncology Based In-Vivo CRO (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Oncology Based In-Vivo CRO (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Oncology Based In-Vivo CRO (Syngeneic) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Oncology Based In-Vivo CRO (Syngeneic) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Oncology Based In-Vivo CRO (Xenograft) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Oncology Based In-Vivo CRO (Xenograft) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Oncology Based In-Vivo CRO (Other Models) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Oncology Based In-Vivo CRO (Other Models) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Oncology Based In-Vivo CRO (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Oncology Based In-Vivo CRO (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: North America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: North America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: United States: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: United States: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Canada: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Canada: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Asia-Pacific: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Asia-Pacific: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: China: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: China: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Japan: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Japan: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: India: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: India: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: South Korea: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: South Korea: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Australia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Australia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Indonesia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Indonesia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Europe: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Europe: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Germany: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Germany: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: France: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: France: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: United Kingdom: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: United Kingdom: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Italy: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Italy: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Spain: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Spain: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Russia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Russia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Latin America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Latin America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Brazil: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Brazil: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Mexico: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Mexico: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Middle East and Africa: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Middle East and Africa: Oncology Based In-Vivo CRO Market: Breakup by Country (in %), 2023
- Figure 74: Middle East and Africa: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Global: Oncology Based In-Vivo CRO Industry: SWOT Analysis
- Figure 76: Global: Oncology Based In-Vivo CRO Industry: Value Chain Analysis
- Figure 77: Global: Oncology Based In-Vivo CRO Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Oncology Based In-Vivo CRO Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Indication (in Million US$), 2024-2032
- Table 3: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Model (in Million US$), 2024-2032
- Table 4: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 5: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Oncology Based In-Vivo CRO Market: Competitive Structure
- Table 7: Global: Oncology Based In-Vivo CRO Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.